• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道肿瘤微环境。

The Intestinal Tumour Microenvironment.

机构信息

Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

Maurice Wilkins Centre for Biodiscovery, Auckland, New Zealand.

出版信息

Adv Exp Med Biol. 2020;1226:1-22. doi: 10.1007/978-3-030-36214-0_1.

DOI:10.1007/978-3-030-36214-0_1
PMID:32030672
Abstract

The tumour microenvironment (TME) of intestinal tumours is highly complex and comprises a network of stromal cells, tumour cells, immune cells and fibroblasts, as well as microorganisms. The tumour location, environmental factors and the tumour cells themselves influence the cells within the TME. Immune cells can destroy tumour cells and are associated with better patient prognosis and response to therapy; however, immune cells are highly plastic and easily influenced to instead promote tumour growth. The interaction between local immune cells and the microbiome can lead to progression or regression of intestinal tumours. In this chapter, we will discuss how tumour development and progression can influence, and be influenced by, the microenvironment surrounding it, focusing on immune and fibroblastic cells, and the intestinal microbiota, particularly in the context of colorectal cancer.

摘要

肠道肿瘤的肿瘤微环境(TME)非常复杂,包含了基质细胞、肿瘤细胞、免疫细胞和成纤维细胞网络,以及微生物群。肿瘤位置、环境因素和肿瘤细胞本身都会影响 TME 中的细胞。免疫细胞可以破坏肿瘤细胞,并与更好的患者预后和对治疗的反应相关;然而,免疫细胞具有高度的可塑性,很容易受到影响转而促进肿瘤生长。局部免疫细胞和微生物组之间的相互作用可导致肠道肿瘤的进展或消退。在本章中,我们将讨论肿瘤的发展和进展如何影响其周围的微环境,以及如何受其影响,重点讨论免疫和成纤维细胞,以及肠道微生物群,特别是在结直肠癌的背景下。

相似文献

1
The Intestinal Tumour Microenvironment.肠道肿瘤微环境。
Adv Exp Med Biol. 2020;1226:1-22. doi: 10.1007/978-3-030-36214-0_1.
2
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
3
Friend or foe? The tumour microenvironment dilemma in colorectal cancer.敌友?结直肠癌细胞微环境的困境。
Biochim Biophys Acta Rev Cancer. 2017 Jan;1867(1):1-18. doi: 10.1016/j.bbcan.2016.11.001. Epub 2016 Nov 16.
4
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.具核梭杆菌与结直肠癌免疫及分子改变的关联
World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557.
5
Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.改变肿瘤微环境和逆转肿瘤细胞:治疗恶性肿瘤的新策略。
Cell Prolif. 2020 Aug;53(8):e12865. doi: 10.1111/cpr.12865. Epub 2020 Jun 26.
6
Influence of the gut microbiota on immune cell interactions and cancer treatment.肠道微生物群对免疫细胞相互作用和癌症治疗的影响。
J Transl Med. 2024 Oct 15;22(1):939. doi: 10.1186/s12967-024-05709-3.
7
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.具核梭杆菌与结直肠癌中的 T 细胞
JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.
8
The expression and role of CXC chemokines in colorectal cancer.CXC 趋化因子在结直肠癌中的表达和作用。
Cytokine Growth Factor Rev. 2011 Oct-Dec;22(5-6):345-58. doi: 10.1016/j.cytogfr.2011.09.002. Epub 2011 Oct 14.
9
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.肿瘤微环境与癌症和癌症干细胞中的代谢可塑性:耐药性卵巢癌干细胞中代谢和免疫调节特征的观点。
Semin Cancer Biol. 2018 Dec;53:265-281. doi: 10.1016/j.semcancer.2018.10.002. Epub 2018 Oct 11.
10
The inflammatory pathogenesis of colorectal cancer.结直肠癌的炎症发病机制。
Nat Rev Immunol. 2021 Oct;21(10):653-667. doi: 10.1038/s41577-021-00534-x. Epub 2021 Apr 28.

引用本文的文献

1
Mitochondrial genome transfer drives metabolic reprogramming in adjacent colonic epithelial cells promoting TGFβ1-mediated tumor progression.线粒体基因组转移驱动相邻结肠上皮细胞的代谢重编程,促进 TGFβ1 介导的肿瘤进展。
Nat Commun. 2024 Apr 30;15(1):3653. doi: 10.1038/s41467-024-48100-y.
2
Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?结直肠癌精准医学中的液体活检方法与免疫疗法:我们做到了吗?
Front Oncol. 2023 Jan 6;12:1023565. doi: 10.3389/fonc.2022.1023565. eCollection 2022.
3
Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers.
遗传突变和肿瘤微生物群决定肿瘤免疫特征的异质性:来自胃和结直肠同步癌的证据。
Front Immunol. 2022 Nov 7;13:947080. doi: 10.3389/fimmu.2022.947080. eCollection 2022.
4
Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer.结肠癌患者结肠腔微生物群的宏蛋白质组学特征
Front Microbiol. 2022 Apr 14;13:869523. doi: 10.3389/fmicb.2022.869523. eCollection 2022.
5
Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment.卡立宾A对多细胞肿瘤微环境中结直肠癌细胞恶性肿瘤的多靶点作用
Front Oncol. 2021 Sep 29;11:650603. doi: 10.3389/fonc.2021.650603. eCollection 2021.
6
Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.基于生物信息学方法鉴定结直肠癌肿瘤微环境相关预后基因。
Sci Rep. 2021 Jul 22;11(1):15040. doi: 10.1038/s41598-021-94541-6.
7
Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.TCGA 数据库中肿瘤微环境相关基因对直肠癌的预后价值。
J Cell Mol Med. 2021 Jun;25(12):5811-5822. doi: 10.1111/jcmm.16547. Epub 2021 May 5.
8
Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut.肠道中免疫细胞和上皮细胞之间的细胞因子介导的串扰。
Cells. 2021 Jan 9;10(1):111. doi: 10.3390/cells10010111.